betamethasone has been researched along with Corneal Angiogenesis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahar, I; Eiger-Moscovich, M; Gal-Or, O; Livnat, T; Livny, E; Nisgav, Y; Sella, R | 1 |
Amoli, FA; Hashemian, MN; Kiumehr, S; Moghimi, S; Riazi, M | 1 |
Shimazaki, J; Shimmura, S; Tomita, M; Tsubota, K | 1 |
Casey, R; Folkman, J; Gonzalez, EM; Li, WW | 1 |
4 other study(ies) available for betamethasone and Corneal Angiogenesis
Article | Year |
---|---|
Comparison of Subconjunctival Aflibercept and Betamethasone for the Treatment of Formed Corneal Neovascularization in a Rabbit Model.
Topics: Angiogenesis Inhibitors; Animals; Betamethasone; Corneal Neovascularization; Disease Models, Animal; Female; Glucocorticoids; Injections, Intraocular; Rabbits; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A | 2019 |
Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Bevacizumab; Conjunctiva; Cornea; Corneal Neovascularization; Disease Models, Animal; Glucocorticoids; Injections; Male; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |
Postkeratoplasty atopic sclerokeratitis in keratoconus patients.
Topics: Adult; Betamethasone; Blepharitis; Corneal Neovascularization; Cyclosporine; Dermatitis, Atopic; Female; Humans; Hypersensitivity, Immediate; Immunosuppressive Agents; Incidence; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Scleritis; Time Factors; Visual Acuity | 2008 |
Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
Topics: Administration, Topical; Angiogenesis Inducing Agents; Animals; beta-Cyclodextrins; Betamethasone; Corneal Neovascularization; Cortodoxone; Cyclodextrins; Disease Models, Animal; Drug Synergism; Hydrocortisone; Male; Rabbits | 1991 |